EP3083681
MÓTEFNASTÝRÐ TRANSTÝRETÍN-MEÐFERÐ (TTR) VIÐ MÝLILDI OG MÓTEFNI TIL ÞESS UNNIN ÚR MÖNNUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
22.12.2014EP published:
22.7.2020EP application number:
14833579.7
EP translation filed:
19.8.2020Grant published:
15.9.2020EPO information:
European Patent Register
Max expiry date:
21.12.2034Expiry date:
21.12.2026Next due date:
31.12.2026
Title:
ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR
Timeline
Today
22.12.2014EP application
22.7.2020EP Publication
19.8.2020Translation submitted
15.9.2020Registration published
21.12.2026Expires
Owner
Name:
Neurimmune Holding AGAddress:
Wagistrasse 18, 8952 Schlieren, CH
Inventor
Name:
GRIMM, JanAddress:
CH-8600 Dübendorf, CH
Name:
MICHALON, AubinAddress:
CH-5400 Baden, CH
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
13199251Date:
20.12.2013Country:
EP
Classification
Categories:
C07K 16/18
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 14.12.2020
Expires: 21.12.2021
Payer: Patice ehf.
Number: 8
Paid: 16.12.2021
Expires: 21.12.2022
Payer: Patice ehf.
Number: 9
Paid: 22.12.2022
Expires: 21.12.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 15.12.2023
Expires: 21.12.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 10.12.2024
Expires: 21.12.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 15.12.2025
Expires: 21.12.2026
Payer: Árnason Faktor ehf.